{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:14:01Z","timestamp":1774502041625,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01020-2","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:10:04Z","timestamp":1754640604000},"page":"797-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of anticoagulation-related nephropathy complicated by IgA nephropathy that developed following the long-term use of anticoagulants"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-9398","authenticated-orcid":false,"given":"Yuko","family":"Oyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Iwafuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"1020_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijcard.2018.02.075","volume":"265","author":"YH Chan","year":"2018","unstructured":"Chan YH, Yeh YH, Hsieh MY, Chang CY, Tu HT, Chang SH, et al. The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: a nationwide cohort study in Taiwan. Int J Cardiol. 2018;265:83\u20139.","journal-title":"Int J Cardiol"},{"key":"1020_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12959-021-00351-1","volume":"19","author":"WC Lee","year":"2021","unstructured":"Lee WC, Lee PW, Wu PJ, Fang YN, Chen HC, Lin YS, et al. The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients. Thromb J. 2021;19:98.","journal-title":"Thromb J"},{"key":"1020_CR4","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1681\/ASN.2018070741","volume":"29","author":"S Brodsky","year":"2018","unstructured":"Brodsky S, Eikelboom J, Hebert LA. Anticoagulant-related nephropathy. J Am Soc Nephrol. 2018;29:2787\u201393.","journal-title":"J Am Soc Nephrol"},{"key":"1020_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","volume":"54","author":"SV Brodsky","year":"2009","unstructured":"Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis. 2009;54:1121\u20136.","journal-title":"Am J Kidney Dis"},{"key":"1020_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jth.13229","volume":"14","author":"DS Wheeler","year":"2016","unstructured":"Wheeler DS, Giugliano RP, Rangaswami J. Anticoagulation-related nephropathy. J Thromb Haemost. 2016;14:461\u20137.","journal-title":"J Thromb Haemost"},{"key":"1020_CR7","doi-asserted-by":"crossref","unstructured":"Iwafuchi Y, Ito Y, Imai N, Oyama Y, Narita I. A case of dabigatran-related nephropathy complicated by tubulointerstitial nephritis in a patient with a normal renal function and undiagnosed IgA nephropathy. Intern Med. 2024;63(11):1615\u201321.","DOI":"10.2169\/internalmedicine.2628-23"},{"key":"1020_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ki.2011.44","volume":"80","author":"SV Brodsky","year":"2011","unstructured":"Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011;80:181\u20139.","journal-title":"Kidney Int"},{"key":"1020_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ekir.2022.01.1048","volume":"7","author":"H Trujillo","year":"2022","unstructured":"Trujillo H, Sandino J, Cavero T, Caravaca-Fontan F, Gutierrez E, Sevillano AM, et al. IgA nephropathy is the most common underlying disease in patients with anticoagulant-related nephropathy. Kidney Int Rep. 2022;7:831\u201340.","journal-title":"Kidney Int Rep"},{"key":"1020_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/ijms20092205","volume":"20","author":"JA Moreno","year":"2019","unstructured":"Moreno JA, Sevillano A, Gutierrez E, Guerrero-Hue M, Vazquez-Carballo C, Yuste C, et al. Glomerular hematuria: cause or consequence of renal inflammation? Int J Mol Sci. 2019;20:2205.","journal-title":"Int J Mol Sci"},{"key":"1020_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/0272-6386(95)90058-6","volume":"26","author":"C Zoja","year":"1995","unstructured":"Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis. 1995;26:934\u201341.","journal-title":"Am J Kidney Dis"},{"key":"1020_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ndt\/10.5.591","volume":"10","author":"SN Heyman","year":"1995","unstructured":"Heyman SN, Brezis M. Acute renal failure in glomerular bleeding: a puzzling phenomenon. Nephrol Dial Transplant. 1995;10:591\u20133.","journal-title":"Nephrol Dial Transplant"},{"key":"1020_CR13","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.3390\/ijms23137016","volume":"23","author":"M Xu","year":"2022","unstructured":"Xu M, Lichtenberger FB, Erdogan C, Lai E, Persson PB, Patzak A, et al. Nitric oxide signalling in descending vasa recta after hypoxia\/re-oxygenation. Int J Mol Sci. 2022;23:7016.","journal-title":"Int J Mol Sci"},{"key":"1020_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ki.1984.185","volume":"26","author":"M Brezis","year":"1984","unstructured":"Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int. 1984;26:375\u201383.","journal-title":"Kidney Int"},{"key":"1020_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ckj\/sft076","volume":"6","author":"GW Moeckel","year":"2013","unstructured":"Moeckel GW, Luciano RL, Brewster UC. Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin. Clin Kidney J. 2013;6:507\u20139.","journal-title":"Clin Kidney J"},{"key":"1020_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1432-2277.2007.00538.x","volume":"20","author":"MR Moussavian","year":"2007","unstructured":"Moussavian MR, Slotta JE, Kollmar O, Menger MD, Schilling MK, Gronow G. Hemoglobin induces cytotoxic damage of glycine-preserved renal tubules. Transpl Int. 2007;20:884\u201394.","journal-title":"Transpl Int"},{"key":"1020_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2215\/CJN.01970211","volume":"7","author":"JA Moreno","year":"2012","unstructured":"Moreno JA, Martin-Cleary C, Gutierrez E, Toldos O, Blanco-Colio LM, Praga M, et al. AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol. 2012;7:175\u201384.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1020_CR18","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.34067\/KID.0004832022","volume":"3","author":"RD Singh","year":"2022","unstructured":"Singh RD, Croatt AJ, Ackerman AW, Grande JP, Trushina E, Salisbury JL, et al. Prominent mitochondrial injury as an early event in heme protein-induced acute kidney injury. Kidney360. 2022;3:1672\u201382.","journal-title":"Kidney360"},{"key":"1020_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1582-4934.2002.tb00452.x","volume":"6","author":"T Wakabayashi","year":"2002","unstructured":"Wakabayashi T. Megamitochondria formation\u2014physiology and pathology. J Cell Mol Med. 2002;6:497\u2013538.","journal-title":"J Cell Mol Med"},{"key":"1020_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010;50:323\u201354.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1020_CR21","first-page":"301","volume":"10","author":"K Mezue","year":"2020","unstructured":"Mezue K, Ram P, Egbuche O, Menezes RG, Lerma E, Rangaswami J. Anticoagulation-related nephropathy for the internist: a concise review. Am J Cardiovasc Dis. 2020;10:301\u20135.","journal-title":"Am J Cardiovasc Dis"},{"key":"1020_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2022.12.002","volume":"222","author":"S Chen","year":"2023","unstructured":"Chen S, Liao D, Yang M, Wang S. Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: clinical characteristics, treatments and outcomes. Thromb Res. 2023;222:20\u20133.","journal-title":"Thromb Res"},{"key":"1020_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/00185787211016335","volume":"57","author":"F Marchesini","year":"2022","unstructured":"Marchesini F, Ossato A, Zendrini A, Arginelli F, Zuppini T, Realdon N, et al. Dabigatran-induced nephropathy and gastrointestinal bleeding and its successful treatment with idarucizumab: a case report. Hosp Pharm. 2022;57:241\u20135.","journal-title":"Hosp Pharm"},{"key":"1020_CR24","doi-asserted-by":"publisher","first-page":"e230371","DOI":"10.1136\/bcr-2019-230371","volume":"12","author":"C DiMaria","year":"2019","unstructured":"DiMaria C, Hanna W, Murone J, Reichart J. Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis. BMJ Case Rep. 2019;12:e230371.","journal-title":"BMJ Case Rep"},{"key":"1020_CR25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3390\/jcm10040796","volume":"10","author":"T Belcic Mikic","year":"2021","unstructured":"Belcic Mikic T, Kojc N, Frelih M, Ales-Rigler A, Veceric-Haler Z. Management of anticoagulant-related nephropathy: a single center experience. J Clin Med. 2021;10:796.","journal-title":"J Clin Med"},{"key":"1020_CR26","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1111\/bcp.14688","volume":"87","author":"S Mitsuboshi","year":"2021","unstructured":"Mitsuboshi S, Niimura T, Zamami Y, Ishizawa K. Differences in risk factors for anticoagulant-related nephropathy between warfarin and direct oral anticoagulants: analysis of the Japanese adverse drug event report database. Br J Clin Pharmacol. 2021;87:2977\u201381.","journal-title":"Br J Clin Pharmacol"},{"key":"1020_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2215\/CJN.13251118","volume":"14","author":"AM Sevillano","year":"2019","unstructured":"Sevillano AM, Diaz M, Caravaca-Fontan F, Barrios C, Bernis C, Cabrera J, et al. IgA nephropathy in elderly patients. Clin J Am Soc Nephrol. 2019;14:1183\u201392.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1020_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000337918","volume":"35","author":"A Ozcan","year":"2012","unstructured":"Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, et al. 5\/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol. 2012;35:356\u201364.","journal-title":"Am J Nephrol"},{"key":"1020_CR29","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1681\/ASN.2010101110","volume":"22","author":"K Ware","year":"2011","unstructured":"Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, et al. Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol. 2011;22:1856\u201362.","journal-title":"J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01020-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:12:45Z","timestamp":1762845165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01020-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from the participant in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}